Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis

Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summarize data on PZA resistance in clinical isolates from South Africa. PZA DST should be performed when considering its inclusion in treatment of patients with rifampicin-resistant TB or MDR-TB.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tuberculosis (Edinb)
Hauptverfasser: Whitfield, M.G., Streicher, E.M., Dolby, T., Simpson, J.A, Sampson, S.L., Van Helden, P.D., Van Rie, A., Warren, R.M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963978/
https://ncbi.nlm.nih.gov/pubmed/27450014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2016.05.003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge